Fresenius Kabi Deutschland GmbH

Freseniusstr. 1
61169 Friedberg
Germany

Phone

fresenius-kabi.de

About Fresenius

Product portfolio of Fresenius

Product portfolio

Show all

Robust glass columns for demanding MPLC applications

Automated Filter Integrity Testing With Advanced Quality Risk Management for GMP Compliance

Maximum binding capacity in ion exchange chromatography

News about Fresenius

25-Apr-2017 | business & finance

Merck Divests Biosimilars Business to Fresenius

Merck announced the divestment of its Biosimilars business to Fresenius. The decision to divest Biosimilars is aligned with Merck’s strategy for its ...

Read news

31-Jan-2011 | business & finance

Swedish Orphan Biovitrum agrees with Fresenius Biotech to distribute Removab

Swedish Orphan Biovitrum announced a Removab® distribution agreement with Fresenius Biotech. Under the agreement Swedish Orphan Biovitrum (Sobi) will ...

Read news

29-Oct-2010 | research and development

Trifunctional antibody Removab from Fresenius Biotech awarded Galenus von Pergamon Prize for drug innovation

The trifunctional antibody Removab® (Catumaxomab) from Fresenius Biotech was awarded this year’s Galenus von Pergamon Prize in the “Specialist Care” ...

Read news

15-Jan-2010 | business & finance

Fresenius Kabi and Bayer Schering Pharma extend collaboration regarding HESylation Technology

Fresenius Kabi Deutschland GmbH and Bayer Schering Pharma AG have extended their collaboration in the field of HESylation® Technology. The companies ...

Read news

30-Oct-2009 | business & finance

Fresenius Kabi and Octapharma Group enter into an Exclusive Agreement for a HESylated recombinant protein

Fresenius Kabi and Octapharma Group have signed a License, Development and Supply Agreement regarding the use of Fresenius Kabi’s HESylation® Technology to ...

Read news

09-Jun-2009 | business & finance

BioNTech AG acquires EUFETS AG

BioNTech AG announced the acquisition of all shares of EUFETS AG from Fresenius Biotech GmbH (Munich, Germany). EUFETS, formerly a fully owned subsidiary ...

Read news

04-Jun-2009 | business & finance

Fresenius Kabi and Bayer Schering Pharma enter into a Research, Development and License Agreement

Fresenius Kabi Deutschland GmbH and Bayer Schering Pharma AG have signed a Research, Development and License Agreement regarding the use of Fresenius Kabi ...

Read news

27-Apr-2009 | research and development

Removab Approval: Proof-of-Concept for Technology Transfer in Germany

The European Commission has granted approval for the trifunctional anti-cancer antibody Removab®. It is the first approved therapeutic antibody originating ...

Read news

08-Jul-2008 | business & finance

Fresenius to acquire US drug-maker APP Pharmaceuticals in US$3.7 billion deal

Fresenius SE said Monday that it reached a deal to buy U.S. generic drug maker APP Pharmaceuticals in a US$3.7 billion deal that will give the German ...

Read news

10-Jan-2006 | business & finance

Enzon Returns Rights To Transplantation Product To Fresenius Biotech

Enzon Pharmaceuticals, Inc. announced that it is returning its rights to ATG-Fresenius S to Fresenius Biotech GmbH, a subsidiary of the health care company ...

Read news

Show more news about Fresenius

First CO₂ Incubator Shaker with Integrated 180°C Sterilization